{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:52:26Z","timestamp":1791305546509,"version":"4.3.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Extrapulmonary tuberculosis (EPTB) accounts for a substantial proportion of the global tuberculosis (TB) burden and continues to pose major diagnostic and therapeutic challenges, particularly in low-incidence settings. Comprehensive descriptions of the clinical spectrum, diagnostic yield of available laboratory modalities, and treatment-related toxicity of EPTB in the Arabian Gulf are limited. We aimed to describe the clinical characteristics, diagnostic performance of microbiological and histopathological tests, and safety profile of first-line anti-TB therapy in adult patients with EPTB managed at a tertiary care hospital in Oman.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This was a single-center, retrospective cohort study conducted at Sultan Qaboos University Hospital (SQUH), University Medical City, Muscat, Sultanate of Oman, and reported in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology statement. All adults (\u226518 years) with a confirmed diagnosis of EPTB between January 2010 and January 2020 and at least 12 months of follow-up were enrolled by consecutive purposive sampling. Demographic, clinical, microbiological (acid-fast bacilli [AFB] smear, GeneXpert\n                      <jats:italic toggle=\"yes\">Mycobacterium<\/jats:italic>\n                      tuberculosis\/rifampicin [Xpert MTB\/RIF], mycobacterial culture), histopathological, radiological, treatment, and adverse-event data were extracted from the hospital electronic record (TrakCare). Categorical variables were summarized as frequencies and percentages, and continuous variables as mean \u00b1 standard deviation; the \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      or Fisher\u2019s exact test was used as appropriate, with a two-tailed\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05 considered significant. Analyses were performed using IBM SPSS Statistics version 27.0.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of 225 patients with confirmed TB during the study period, 46 (20.4%) had EPTB and were included. The mean age was 41.5 \u00b1 16.5 years, and 30 (65.2%) were male. Tuberculous (TB) lymphadenitis and disseminated TB were the most common forms (13\/46, or 28.3%), followed by musculoskeletal (7, or 15.2%), pleural, abdominal, and meningeal TB (4 each, or 8.7%), and genitourinary TB (1, or 2.2%). Five patients (10.9%) were co-infected with human immunodeficiency virus (HIV), and 3 (6.5%) were on systemic immunosuppression. Constitutional symptoms were uncommon: fever, 39%; night sweats and weight loss, 13% each. AFB smear and mycobacterial culture had the highest yield in TB lymphadenitis (85% and 77%), Xpert MTB\/RIF in tuberculous meningitis (75% of cerebrospinal fluid [CSF] samples), and histopathology in gastrointestinal TB (75%). All 46 patients received standard four-drug therapy; drug-induced liver injury (DILI) occurred in 19.6%, gastrointestinal intolerance in 9%, peripheral neuropathy in 7%, and cytopenia in 2%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>EPTB represents one-fifth of the TB caseload at a tertiary center in Oman, with TB lymphadenitis and disseminated disease as the leading forms. The diagnostic yield of individual tests varies markedly by anatomical site, supporting a multimodal approach combining AFB smear, Xpert MTB\/RIF, mycobacterial culture, and histopathology on every available specimen. Hepatotoxicity remains the dominant treatment-limiting adverse event and warrants systematic monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijmy.ijmy_106_26","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:00:16Z","timestamp":1790823616000},"page":"227-234","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Characteristics, Diagnostic Performance, and Treatment Outcomes of Extrapulmonary Tuberculosis at a Tertiary Care Center in Oman: A 10-year Retrospective Cohort"],"prefix":"10.4103","volume":"15","author":[{"given":"Omar","family":"Al-Busaidi","sequence":"first","affiliation":[{"name":"College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Al-Subhi","sequence":"additional","affiliation":[{"name":"College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5126-1276","authenticated-orcid":false,"given":"Ibrahim","family":"Al-Busaidi","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Medicine, Sultan Qaboos University Hospital, University Medical City, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"R2-20261006","doi-asserted-by":"crossref","first-page":"107325","DOI":"10.1016\/j.ijid.2024.107325","article-title":"Insights from the 2024 WHO Global Tuberculosis Report - More Comprehensive Action, Innovation, and Investments required for achieving WHO End TB goals","volume":"150","author":"Goletti","year":"2025","journal-title":"Int J Infect Dis"},{"key":"R3-20261006","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1148\/rg.2019190109","article-title":"Extrapulmonary tuberculosis: Pathophysiology and imaging findings","volume":"39","author":"Rodriguez-Takeuchi","year":"2019","journal-title":"Radiographics"},{"key":"R4-20261006","doi-asserted-by":"crossref","first-page":"107601","DOI":"10.1016\/j.rmed.2024.107601","article-title":"Diagnosis of extra pulmonary tuberculosis: An update on novel diagnostic approaches","volume":"225","author":"Jain","year":"2024","journal-title":"Respir Med"},{"key":"R5-20261006","first-page":"170","article-title":"Extrapulmonary tuberculosis","volume":"159","author":"Sharma","year":"2004","journal-title":"Indian J Med Res"},{"key":"R6-20261006","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/605559","article-title":"Epidemiology of extrapulmonary tuberculosis in the United States, 1993\u20132006","volume":"49","author":"Peto","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R7-20261006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18295\/squmj.2.2022.019","article-title":"Oman, a Pathfinder Towards Tuberculosis Elimination: The journey begins","volume":"22","author":"Al Yaquobi","year":"2022","journal-title":"Sultan Qaboos Univ Med J"},{"key":"R8-20261006","first-page":"175","article-title":"Towards the elimination of tuberculosis in a developing country: 25 years of tuberculosis control in Oman","volume":"11","author":"Al-Maniri","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"R9-20261006","doi-asserted-by":"crossref","first-page":"e0242023","DOI":"10.1128\/spectrum.02420-23","article-title":"Mycobacterium tuberculosis epidemiology in Oman: whole-genome sequencing uncovers transmission pathways","volume":"11","author":"Babiker","year":"2023","journal-title":"Microbiol Spectr"},{"key":"R10-20261006","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4103\/ijmy.ijmy_31_17","article-title":"Epidemiology of extrapulmonary and disseminated tuberculosis in a tertiary care center in Oman","volume":"6","author":"Gaifer","year":"2017","journal-title":"Int J Mycobacteriol"},{"key":"R11-20261006","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/ijmy.ijmy_188_19","article-title":"Epidemiological profile and surveillance activity of tuberculosis in South Batinah, Oman, 2017 and 2018","volume":"9","author":"Al Mayahi","year":"2020","journal-title":"Int J Mycobacteriol"},{"key":"R12-20261006","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","article-title":"Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: A multicentre implementation study","volume":"377","author":"Boehme","year":"2011","journal-title":"Lancet"},{"key":"R13-20261006","article-title":"Xpert MTB\/RIF ultra and Xpert MTB\/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults","volume":"1","author":"Kohli","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"R14-20261006","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1186\/s12879-019-4687-7","article-title":"Evaluation of GeneXpert MTB\/RIF system performances in the diagnosis of extrapulmonary tuberculosis","volume":"19","author":"Mechal","year":"2019","journal-title":"BMC Infect Dis"},{"key":"R15-20261006","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1473-3099(17)30474-7","article-title":"Diagnostic accuracy of Xpert MTB\/RIF ultra for tuberculous meningitis in HIV-infected adults: A prospective cohort study","volume":"18","author":"Bahr","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"R16-20261006","doi-asserted-by":"crossref","first-page":"e24185","DOI":"10.1002\/jcla.24185","article-title":"Accuracy of Xpert MTB\/RIF assay for the diagnosis of tuberculous pleural effusion","volume":"36","author":"Qiu","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"R17-20261006","doi-asserted-by":"crossref","first-page":"e0321507","DOI":"10.1371\/journal.pone.0321507","article-title":"Exploring the accuracy of the Xpert MTB\/RIF assay in detecting lymph node tuberculosis: A systematic review and meta-analysis","volume":"20","author":"Chen","year":"2025","journal-title":"PLoS One"},{"key":"R18-20261006","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American Thoracic Society\/Centers for disease control and prevention\/infectious diseases Society of America Clinical Practice Guidelines: Treatment of drug-susceptible tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R20-20261006","doi-asserted-by":"crossref","first-page":"8266878","DOI":"10.1155\/2022\/8266878","article-title":"Incidence and Temporal Trend of Antituberculosis Drug-Induced Liver Injury: A Systematic Review and Meta-Analysis","volume":"2022","author":"Wang","year":"2022","journal-title":"J Trop Med"},{"key":"R21-20261006","doi-asserted-by":"crossref","first-page":"1406454","DOI":"10.3389\/fphar.2024.1406454","article-title":"Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury","volume":"15","author":"Liu","year":"2024","journal-title":"Front Pharmacol"},{"key":"R22-20261006","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"R23-20261006","doi-asserted-by":"crossref","first-page":"100681","DOI":"10.1016\/j.ijregi.2025.100681","article-title":"Ending tuberculosis in Gulf Cooperation Council countries: an overview of the WHO End TB Strategy 2025 milestones","volume":"16","author":"Al Awaidy","year":"2025","journal-title":"IJID Reg"},{"key":"R24-20261006","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/ijmy.ijmy_172_24","article-title":"Navigating Extrapulmonary Tuberculosis: A Case Series from a Tertiary Care Facility Highlighting Rare Presentations, Diagnostic Challenges, Drug Resistance, and Therapeutic Complexities","volume":"13","author":"Pathak","year":"2024","journal-title":"Int J Mycobacteriol"},{"key":"R25-20261006","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/ijmy.ijmy_12_24","article-title":"Disseminated Tuberculosis: A 6-year Case Series Experience in a Tertiary Care Center","volume":"13","author":"A\u00e7ar","year":"2024","journal-title":"Int J Mycobacteriol"},{"key":"R26-20261006","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3390\/jcm8060813","article-title":"Clinical Characteristics and Treatment Outcomes of Definitive Versus Standard Anti-Tuberculosis Therapy in Patients with Tuberculous Lymphadenitis","volume":"8","author":"Ko","year":"2019","journal-title":"J Clin Med"},{"key":"R27-20261006","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4103\/ijmy.ijmy_141_23","article-title":"Disseminated tuberculosis: Clinical presentation, diagnosis, and outcomes in a tertiary-care hospital in Saudi Arabia","volume":"12","author":"Abuabat","year":"2023","journal-title":"Int J Mycobacteriol"},{"key":"R28-20261006","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/ijmy.ijmy_210_22","article-title":"Identification of Mycobacterium tuberculosis in pulmonary and extrapulmonary specimens of Iranian hospitalized patients during 2017-2021","volume":"12","author":"Salehi","year":"2023","journal-title":"Int J Mycobacteriol"},{"key":"R29-20261006","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.tube.2010.08.006","article-title":"HIV-associated tuberculous meningitis--diagnostic and therapeutic challenges","volume":"90","author":"Marais","year":"2010","journal-title":"Tuberculosis (Edinb)"},{"key":"R30-20261006","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/ijmy.ijmy_233_22","article-title":"Osteoarticular tuberculosis in Central India: Changing epidemiological profile and emerging challenges","volume":"12","author":"Kori","year":"2023","journal-title":"Int J Mycobacteriol"},{"key":"R31-20261006","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12876-022-02171-7","article-title":"Recent advances in the diagnosis of intestinal tuberculosis","volume":"22","author":"Maulahela","year":"2022","journal-title":"BMC Gastroenterol"}],"container-title":["The International Journal of Mycobacteriology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_106_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:02:48Z","timestamp":1791302568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_106_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmy.ijmy_106_26","relation":{},"ISSN":["2212-5531","2212-554X"],"issn-type":[{"value":"2212-5531","type":"print"},{"value":"2212-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2026-05-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}